A study led by scientists at the University of Birmingham has found that one multidrug-resistant (MDR) strain of Escherichia coli—MDR ST131—has the ability to outcompete other strains of E. coli in a healthy gut.
The U.S. Food and Drug Administration (FDA) has updated its Leafy Green STEC Action Plan (LGAP), which outlines the agency’s efforts to reduce foodborne illness outbreaks linked to leafy greens that were caused by Shiga toxin-producing Escherichia coli (STEC).
The Interagency Food Safety Analytics Collaboration (IFSAC)—a joint effort between FDA, CDC, and USDA-FSIS—has published its 2021 report on foodborne illness source attribution for Salmonella, Escherichia coli O157, and Listeria monocytogenes.
Penn State University (PSU) scientists have received a $1 million grant from the U.S. Department of Agriculture (USDA) to assess the level of antimicrobial resistance (AMR) among foodborne bacteria in Puerto Rico's dairy industry and to train farmers and students on AMR mitigation.
The U.S. Centers for Disease Control and Prevention (CDC) has identified a reoccurring, emerging, and persistent (REP) strain of Escherichia coli O157:H7—REPEXH02—that has been implicated in significant foodborne illness outbreaks linked to leafy greens from 2016–2019.
The prevalence of antimicrobial resistance (AMR) in Escherichia coli found on retail beef and pork meat samples in the UK is relatively low, according to surveillance conducted by the UK Animal and Plant Health Agency (APHA).
The National Antimicrobial Resistance Monitoring System (NARMS) recently published its 2020 Integrated Summary, which includes data providing phenotypic and genomic antimicrobial resistance (AMR) trends for Salmonella, Campylobacter, generic Escherichia coli, and Enterococcus isolated from retail meat and food-producing animals.
A recent study, funded by the U.S. Department of Agriculture’s National Institute of Food and Agriculture (USDA’s NIFA), has estimated the economic burden of foodborne illnesses linked to flour and flour-based food products in the U.S. from 2001–2021 to be as high as $258 million. Salmonella and Escherichia coli were implicated pathogens.